Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $60,700,210 |
Sells | 129 | $20,005,523 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
23 Aug 2024 16:15 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 21 Aug 2024 | Sale | 3,164 | 31.84 | 100,742 | D |
23 Aug 2024 16:15 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 21 Aug 2024 | Sale | 131 | 32.32 | 4,234 | D |
23 Aug 2024 16:10 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 21 Aug 2024 | Sale | 120 | 32.32 | 3,878 | D |
23 Aug 2024 16:10 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 21 Aug 2024 | Sale | 2,907 | 31.84 | 92,559 | D |
23 Aug 2024 16:11 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 21 Aug 2024 | Sale | 149 | 32.32 | 4,816 | D |
23 Aug 2024 16:11 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 21 Aug 2024 | Sale | 3,619 | 31.84 | 115,229 | D |
23 Aug 2024 16:14 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 21 Aug 2024 | Sale | 120 | 32.32 | 3,878 | D |
23 Aug 2024 16:14 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 21 Aug 2024 | Sale | 2,907 | 31.84 | 92,559 | D |
23 Aug 2024 16:07 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 21 Aug 2024 | Sale | 598 | 32.32 | 19,327 | D |
23 Aug 2024 16:07 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 21 Aug 2024 | Sale | 14,470 | 31.84 | 460,725 | D |
26 Jul 2024 16:19 | IMVT | Immunovant Inc | GEFFNER MICHAEL | Chief Medical Officer | 24 Jul 2024 | Sale | 3,456 | 27.76 | 95,939 | D |
26 Jul 2024 16:20 | IMVT | Immunovant Inc | STOUT JAY S | Chief Technology Officer | 24 Jul 2024 | Sale | 2,813 | 27.76 | 78,089 | D |
26 Jul 2024 16:17 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 24 Jul 2024 | Sale | 4,015 | 27.76 | 111,456 | D |
19 Jul 2024 17:39 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 17 Jul 2024 | Sale | 184 | 30.55 | 5,621 | D |
19 Jul 2024 17:39 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 17 Jul 2024 | Sale | 2,939 | 29.64 | 87,112 | D |
19 Jul 2024 17:41 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 17 Jul 2024 | Sale | 504 | 29.64 | 14,939 | D |
19 Jul 2024 17:41 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 17 Jul 2024 | Sale | 31 | 30.55 | 947 | D |
19 Jul 2024 17:41 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 17 Jul 2024 | Sale | 147 | 30.55 | 4,491 | D |
19 Jul 2024 17:41 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 17 Jul 2024 | Sale | 2,362 | 29.64 | 70,010 | D |
19 Jul 2024 17:42 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 17 Jul 2024 | Sale | 147 | 30.55 | 4,491 | D |
19 Jul 2024 17:42 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 17 Jul 2024 | Sale | 2,358 | 29.64 | 69,891 | D |
19 Jul 2024 17:36 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 17 Jul 2024 | Sale | 510 | 30.55 | 15,580 | D |
19 Jul 2024 17:36 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 17 Jul 2024 | Sale | 8,175 | 29.64 | 242,307 | D |
19 Jul 2024 17:38 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 17 Jul 2024 | Sale | 169 | 30.55 | 5,163 | D |
19 Jul 2024 17:38 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 17 Jul 2024 | Sale | 2,698 | 29.64 | 79,969 | D |
10 Jul 2024 17:04 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 09 Jul 2024 | Sale | 4,619 | 28.06 | 129,609 | D |
10 Jul 2024 17:06 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 09 Jul 2024 | Sale | 1,527 | 28.06 | 42,848 | D |
10 Jul 2024 17:07 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 09 Jul 2024 | Sale | 4,747 | 28.06 | 133,201 | D |
24 May 2024 16:14 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 22 May 2024 | Sale | 3,247 | 29.65 | 96,274 | D |
24 May 2024 16:15 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 22 May 2024 | Sale | 16,163 | 29.65 | 479,233 | D |
24 May 2024 16:18 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 22 May 2024 | Sale | 4,042 | 29.65 | 119,845 | D |
24 May 2024 16:10 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 22 May 2024 | Sale | 3,242 | 29.65 | 96,125 | D |
24 May 2024 16:13 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 22 May 2024 | Sale | 3,247 | 29.65 | 96,274 | D |
26 Apr 2024 17:20 | IMVT | Immunovant Inc | STOUT JAY S | Chief Technology Officer | 24 Apr 2024 | Sale | 7,239 | 28.9 | 209,207 | D |
26 Apr 2024 17:22 | IMVT | Immunovant Inc | GEFFNER MICHAEL | Chief Medical Officer | 24 Apr 2024 | Sale | 3,261 | 28.9 | 94,243 | D |
26 Apr 2024 17:18 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 24 Apr 2024 | Sale | 3,963 | 28.9 | 114,531 | D |
19 Apr 2024 18:05 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 17 Apr 2024 | Sale | 79 | 29.94 | 2,365 | D |
19 Apr 2024 18:05 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 17 Apr 2024 | Sale | 269 | 28.8 | 7,747 | D |
19 Apr 2024 18:05 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 17 Apr 2024 | Sale | 1,796 | 29.94 | 53,772 | D |
19 Apr 2024 18:05 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 17 Apr 2024 | Sale | 6,136 | 28.8 | 176,717 | D |
19 Apr 2024 18:06 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 17 Apr 2024 | Sale | 2,225 | 29.94 | 66,616 | D |
19 Apr 2024 18:06 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 17 Apr 2024 | Sale | 7,602 | 28.8 | 218,938 | D |
19 Apr 2024 18:01 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 17 Apr 2024 | Sale | 2,774 | 29.94 | 83,054 | D |
19 Apr 2024 18:01 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 17 Apr 2024 | Sale | 9,479 | 28.8 | 272,995 | D |
19 Apr 2024 17:57 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 17 Apr 2024 | Sale | 7,714 | 29.94 | 230,957 | D |
19 Apr 2024 17:57 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 17 Apr 2024 | Sale | 26,365 | 28.8 | 759,312 | D |
19 Apr 2024 17:59 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 17 Apr 2024 | Sale | 2,290 | 29.94 | 68,563 | D |
19 Apr 2024 17:59 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 17 Apr 2024 | Sale | 7,825 | 28.8 | 225,360 | D |
10 Apr 2024 16:16 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 09 Apr 2024 | Sale | 1,053 | 31.18 | 32,833 | D |
10 Apr 2024 16:18 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 09 Apr 2024 | Sale | 3,689 | 31.18 | 115,023 | D |
10 Apr 2024 16:14 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 09 Apr 2024 | Sale | 4,807 | 31.18 | 149,882 | D |
23 Feb 2024 16:18 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 22 Feb 2024 | Sale | 2,134 | 36.15 | 77,144 | D |
23 Feb 2024 16:21 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 22 Feb 2024 | Sale | 2,930 | 36.15 | 105,920 | D |
23 Feb 2024 16:14 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 22 Feb 2024 | Sale | 2,146 | 36.15 | 77,578 | D |
23 Feb 2024 16:16 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 22 Feb 2024 | Sale | 2,221 | 36.15 | 80,289 | D |
23 Feb 2024 16:11 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 22 Feb 2024 | Sale | 13,454 | 36.15 | 486,362 | D |
29 Jan 2024 16:11 | IMVT | Immunovant Inc | GEFFNER MICHAEL | Chief Medical Officer | 26 Jan 2024 | Sale | 153 | 38.45 | 5,883 | D |
29 Jan 2024 16:11 | IMVT | Immunovant Inc | GEFFNER MICHAEL | Chief Medical Officer | 26 Jan 2024 | Sale | 9,948 | 37.91 | 377,129 | D |
29 Jan 2024 16:12 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 26 Jan 2024 | Sale | 46 | 38.45 | 1,769 | D |
29 Jan 2024 16:12 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 26 Jan 2024 | Sale | 2,981 | 37.91 | 113,010 | D |
19 Jan 2024 16:04 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 18 Jan 2024 | Sale | 424 | 41.03 | 17,397 | D |
12 Jan 2024 16:34 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 11 Jan 2024 | Sale | 834 | 42.43 | 35,387 | D |
12 Jan 2024 16:34 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 11 Jan 2024 | Sale | 2,681 | 41.64 | 111,637 | D |
09 Jan 2024 16:20 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 05 Jan 2024 | Sale | 1,297 | 38.59 | 50,051 | D |
09 Jan 2024 16:18 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 05 Jan 2024 | Sale | 3,824 | 38.59 | 147,568 | D |
05 Dec 2023 16:30 | IMVT | Immunovant Inc | FROMKIN ANDREW J. | Director | 01 Dec 2023 | Sale | 4,773 | 40.46 | 193,116 | D |
05 Dec 2023 16:30 | IMVT | Immunovant Inc | FROMKIN ANDREW J. | Director | 01 Dec 2023 | Sale | 3,636 | 39.81 | 144,749 | D |
05 Dec 2023 16:30 | IMVT | Immunovant Inc | FROMKIN ANDREW J. | Director | 01 Dec 2023 | Sale | 3,941 | 38.78 | 152,832 | D |
05 Dec 2023 16:25 | IMVT | Immunovant Inc | MIGAUSKY GEORGE V | Director | 01 Dec 2023 | Sale | 5,022 | 40.46 | 203,190 | D |
05 Dec 2023 16:25 | IMVT | Immunovant Inc | MIGAUSKY GEORGE V | Director | 01 Dec 2023 | Sale | 3,478 | 39.81 | 138,459 | D |
05 Dec 2023 16:25 | IMVT | Immunovant Inc | MIGAUSKY GEORGE V | Director | 01 Dec 2023 | Sale | 4,200 | 38.79 | 162,918 | D |
05 Dec 2023 16:28 | IMVT | Immunovant Inc | PANDE ATUL | Director | 01 Dec 2023 | Sale | 4,847 | 40.46 | 196,110 | D |
05 Dec 2023 16:28 | IMVT | Immunovant Inc | PANDE ATUL | Director | 01 Dec 2023 | Sale | 3,374 | 39.82 | 134,353 | D |
05 Dec 2023 16:28 | IMVT | Immunovant Inc | PANDE ATUL | Director | 01 Dec 2023 | Sale | 4,129 | 38.8 | 160,205 | D |
24 Nov 2023 14:55 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 22 Nov 2023 | Sale | 15,601 | 32.75 | 510,933 | D |
24 Nov 2023 14:55 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 22 Nov 2023 | Sale | 616 | 33.52 | 20,648 | D |
24 Nov 2023 14:51 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 22 Nov 2023 | Sale | 154 | 33.52 | 5,162 | D |
24 Nov 2023 14:51 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 22 Nov 2023 | Sale | 3,901 | 32.75 | 127,758 | D |
24 Nov 2023 14:45 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 22 Nov 2023 | Sale | 124 | 33.52 | 4,156 | D |
24 Nov 2023 14:45 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 22 Nov 2023 | Sale | 3,141 | 32.75 | 102,868 | D |
24 Nov 2023 14:47 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 22 Nov 2023 | Sale | 3,141 | 32.75 | 102,868 | D |
24 Nov 2023 14:47 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 22 Nov 2023 | Sale | 124 | 33.52 | 4,156 | D |
24 Nov 2023 14:41 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 22 Nov 2023 | Sale | 124 | 33.52 | 4,156 | D |
24 Nov 2023 14:41 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 22 Nov 2023 | Sale | 3,128 | 32.75 | 102,442 | D |
27 Oct 2023 16:04 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 25 Oct 2023 | Sale | 4,107 | 34.66 | 142,349 | D |
20 Oct 2023 16:06 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 19 Oct 2023 | Sale | 530 | 36.8 | 19,504 | D |
11 Oct 2023 16:11 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 10 Oct 2023 | Sale | 4,557 | 36.92 | 168,244 | D |
06 Oct 2023 17:15 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 05 Oct 2023 | Sale | 1,439 | 36.39 | 52,365 | D |
06 Oct 2023 17:15 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 05 Oct 2023 | Sale | 296 | 35.54 | 10,520 | D |
06 Oct 2023 17:10 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 05 Oct 2023 | Sale | 4,345 | 36.39 | 158,115 | D |
06 Oct 2023 17:10 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 05 Oct 2023 | Sale | 894 | 35.54 | 31,773 | D |
04 Oct 2023 17:15 | IMVT | Immunovant Inc | ROIVANT SCIENCES LTD. | Director , 10% | 02 Oct 2023 | Purchase | 1,526,316 | 38 | 58,000,008 | D |
01 Sep 2023 16:08 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 30 Aug 2023 | Sale | 5,908 | 22.48 | 132,812 | D |
01 Sep 2023 16:08 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 30 Aug 2023 | Sale | 50,866 | 21.97 | 1,117,526 | D |
25 Aug 2023 17:05 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 24 Aug 2023 | Sale | 1 | 20.89 | 21 | D |
25 Aug 2023 17:05 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 24 Aug 2023 | Sale | 12,285 | 20.3 | 249,386 | D |
25 Aug 2023 17:00 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 24 Aug 2023 | Sale | 1 | 20.89 | 21 | D |
25 Aug 2023 17:00 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 24 Aug 2023 | Sale | 12,332 | 20.3 | 250,340 | D |
25 Aug 2023 17:03 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 24 Aug 2023 | Sale | 1 | 20.89 | 21 | D |
25 Aug 2023 17:03 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 24 Aug 2023 | Sale | 14,385 | 20.3 | 292,016 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)